Dihydropyridine Calcium Channel Blockers Do Not Increase Risk of Pancreatic Cancer, Study Suggests
New research suggests that, contrary to previous reports, dihydropyridine calcium channel blockers do not increase the risk of pancreatic cancer.
New research suggests that, contrary to previous reports, dihydropyridine calcium channel blockers do not increase the risk of pancreatic cancer.
Extending adjuvant S-1 chemotherapy beyond 6 months after resection of pancreatic ductal adenocarcinoma does not improve outcomes, a real-world study suggests.
Project Renewal is an Oncology Center of Excellence initiative that aims to update the labeling information for certain older oncology drugs.
In a survey of more than 1000 adults, 83% said they are unaware of the signs or symptoms of pancreatic cancer.
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Bariatric surgery may reduce the risk of pancreatic cancer in patients with obesity who are younger than 50 years of age, a study suggests.
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Delivery of radiation to the celiac plexus can decrease pain and opioid use among patients with pancreatic cancer, a phase 2 study suggests.
A diagnosis of PCOS was associated with a 1.9-fold higher risk of pancreatic cancer in a case-control study.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.